Does Corbus Pharmaceuticals Holdings Inc (CRBP) Have What it Takes to be in Your Portfolio Monday?

Corbus Pharmaceuticals Holdings Inc (CRBP) is around the top of the Biotechnology industry according to InvestorsObserver. CRBP received an overall rating of 50, which means that it scores higher than 50 percent of all stocks. Corbus Pharmaceuticals Holdings Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 87 out of the 148 industries.

CRBP has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on CRBP!

See Full CRBP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 50 would rank higher than 50 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Corbus Pharmaceuticals Holdings Inc Stock Today?

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is lower by -1.87% while the S&P 500 is higher by 1.51% as of 3:36 PM on Monday, Nov 29. CRBP is lower by -$0.02 from the previous closing price of $0.88 on volume of 446,911 shares. Over the past year the S&P 500 is up 28.78% while CRBP is lower by -28.69%. CRBP lost -$0.40 per share the over the last 12 months. Click Here to get the full Stock Report for Corbus Pharmaceuticals Holdings Inc stock.